| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |